Catalog
NOVAPEPTLABSPT-14110 MG / VIALRESEARCH USE ONLY

Bremelanotide, MC3R/MC4R Agonist

PT-141

Cyclic heptapeptide melanocortin agonist derived from α-MSH, investigated in central melanocortin receptor signaling and neurobehavioral research models.

MC3R/MC4R bindingCNS receptor signalingNeuroendocrine assays

Specifications

CAS number
189691-06-3
Molecular formula
C50H68N14O10
Molecular weight
1025.16 g/mol
Vial size
10 mg / vial
Purity
≥ 99.1% (HPLC)
Physical form
Lyophilized white powder
Storage
-20 °C, protected from light
Solubility
Bacteriostatic water

Sequence

Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH

Certificate of analysis

Each lot is released with a batch-numbered COA including RP-HPLC chromatogram, ESI-MS identification, sterility and endotoxin results. Reference the lot code on your vial to request the signed document.

Research use only

This material is intended strictly for in-vitro laboratory research. Not for human or veterinary use, diagnostic, therapeutic or food applications.

Scientific references

Selected peer-reviewed literature cited for research context only.

  1. [1]Molinoff PB et al. PT-141 melanocortin agonist. Ann N Y Acad Sci (2003)
  2. [2]Kingsberg SA et al. Bremelanotide clinical program. Obstet Gynecol (2019)